Douglas Ingram

Overview

Douglas Ingram received an average of $29M in total compensation, including $494K in salary, at Sarepta Therapeutics between 2017 and 2018.

Source: SEC filings on April 26, 2019 and April 26, 2018.

Related executives

We found 25 more executives who work or worked at Sarepta Therapeutics.

Gilmore MMSc

Sarepta Therapeutics

Chief Scientific Officer

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

David Howton

Sarepta Therapeutics

General Counsel

Alexander Cumbo

Sarepta Therapeutics

Executive Vice President, Chief Commercial Officer

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

Guriqbal Basi

Sarepta Therapeutics

Chief Scientific Officer

Catherine Stehman-Breen

Sarepta Therapeutics

Chief Medical Officer

Shamim Ruff

Sarepta Therapeutics

Senior Vice President, Regulatory Affairs and Quality

News

You may also like